“…Mycobacterium bovis (bovine mycobacteria), on which the BCG vaccine is based, after 11 years of attenuation (from 1908 to 1919), was deprived of its pathogenicity, which allowed it to be used for the production of an antimycobacterial vaccine [ 11 , 12 , 13 , 14 , 15 , 16 ]. By 1928, 114,000 children had been vaccinated [ 11 ], and although the studies at that time could hardly be assumed to meet the standards of double-blind placebo-controlled trials, the vaccine was considered safe and effective in children [ 17 , 18 , 19 , 20 , 21 , 22 ]. Soon, vaccination was implemented throughout Europe, and after World War II, the WHO recommended expanding the vaccination campaign beyond Europe [ 23 , 24 , 25 ].…”